epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Abilify Asimtufii
    aripiprazole bimonthly injection
  • remove Parlodel
    bromocriptine

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Abilify Asimtufii (aripiprazole bimonthly injection) + Parlodel (bromocriptine)

Monitor/Modify Tx


aripiprazole bimonthly injection + bromocriptine

monitor BP, glucose (type 2 diabetes mellitus patients): combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

Additional Considerations

Smiley face Smiley face aripiprazole bimonthly injection in Abilify Asimtufii

drug interactions apply only to Abilify Asimtufii (aripiprazole bimonthly injection); see other aripiprazole products for potentially relevant interactions

aripiprazole is a substrate of CYP2D6 and CYP3A4; drug interaction guidance may vary with CYP450 inhibitors if patient is CYP2D6 poor metabolizer (PM)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information